ArticleClinical drug investigation2023

Expanded Access Study of Palbociclib Plus Letrozole for Postmenopausal Women with HR+/HER2- Advanced Breast Cancer in Latin America for Whom Letrozole Therapy is Deemed Appropriate.

Luis Fein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.